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Background: Serological investigations of swine influenza virus infections and epidemiological conclusions thereof
are challenging due to the complex and regionally variable pattern of co-circulating viral subtypes and lineages and
varying vaccination regimes. Detection of subtype-specific antibodies currently depends on hemagglutination
inhibition (HI) assays which are difficult to standardize and unsuitable for large scale investigations.
Methods: The nucleocapsid protein (NP) and HA1 fragments of the hemagglutinin protein (HA) of five different
lineages (H1N1av, H1N1pdm, H1pdmN2, H1N2, H3N2) of swine influenza viruses were bacterially expressed and
used as diagnostic antigens in indirect ELISA.
Results: Proteins were co-translationally mono-biotinylated and refolded in vitro into an antigenically authentic
conformation. Western blotting and indirect ELISA revealed highly subtype-specific antigenic characteristics of the
recombinant HA1 proteins although some cross reactivity especially among antigens of the H1 subtype were
evident. Discrimination of antibodies directed against four swine influenza virus subtypes co-circulating in Germany
was feasible using the indirect ELISA format.
Conclusions: Bacterially expressed recombinant NP and HA1 swine influenza virus proteins served as antigens in
indirect ELISAs and provided an alternative to commercial blocking NP ELISA and HI assays concerning generic
(NP-specific) and HA subtype-specific sero-diagnostics, respectively, on a herd basis.
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Swine influenza is an economically important disease of
pigs caused by infections with influenza A viruses (IAV).
Economic losses are caused by retarded growth of fatten-
ing pigs due to influenza-induced or -aggravated respira-
tory disease. In addition, febrile influenza virus infections
in sows may cause fertility problems [1]. Influenza viruses
are an important factor in the polymicrobial respiratory
syndrome of swine [2]. In contrast to human influenza,
infections in swine do not appear to be seasonal, and
virus circulation, especially in larger herds, is observed* Correspondence: timm.harder@fli.bund.de
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reproduction in any medium, provided the oryear-round [3]. Control of swine influenza is difficult
and requires strict zoosanitary measures and herd vaccin-
ation programs. Licensed inactivated whole virus vaccines
are available but high and continuous vaccine coverage
within herds is required [4].
In addition to being affected by disease, pigs are con-
sidered to be an integral part of the wider epidemiology
of influenza, bridging the avian influenza world to mam-
malian influenza. The porcine respiratory epithelium is
lined by cells which express the two sialic acid glycan re-
ceptor structures to which avian- or mammalian-adapted
IAV bind [5]. As such, pigs can be infected by IAV of
human and of avian origin and this provides opportun-
ities for reassortment between these viruses [6,7]. Fol-
lowing historic transspecies transmission events of IAVtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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viruses have established stable circulating lineages in
swine populations worldwide. These porcine lineages
continue to reassort amongst each other and with other
IAV of more recent human or avian origin. In Europe, this
scenario has lead to current presence of at least four
distinct lineages of swine influenza viruses in pig popu-
lations [8,9].
Since the late 1970s IAV of subtype H1N1 of purely
avian origin (H1N1av) dominate the influenza epidemi-
ology in swine in many European countries including
Germany. This lineage, referred to as H1N1av, has fully
adapted to swine and can be distinguished genetically
and antigenically from current avian-adapted H1N1 viruses.
Viruses of this lineage have sporadically been detected
also in humans and turkeys in Europe due to single
transmission events from infected pigs [10,11]. A second
porcine lineage consists of viruses of subtype H3N2. The
progenitor of the currently circulating porcine H3N2
strains originated from human-adapted H3N2 viruses
which had caused the Hong Kong flu pandemic in 1968
[8]. In the early 1980s the descendants of this virus
reassorted with H1N1av and, apart from the hemagglutinin
H3 and the neuraminidase N2 segments, all further six
genome segments were replaced with those of H1N1av
[8]. In the early 1990s, a new porcine triple reassortant
virus, H1N2, arose from reassortment events between
human seasonal H1N1 and H3N2 and porcine H1N1av
viruses. This porcine H1N2 virus carried hemagglutinin
(HA) and neuraminidase (NA) of human origin and the
cassette of six further segments of H1N1av [8]. These
three lineages continue to co-circulate at varying preva-
lences in different European countries.
In 2009, a new human pandemic H1N1 strain (H1N1pdm)
emerged. This virus carried reassorted gene segments
from several American and Eurasian swine influenza line-
ages and was rapidly introduced from the human popu-
lation to pigs [8]. Pigs proved to be highly susceptible to
this virus and stable transmission chains were easily
maintained [12]. To date H1N1pdm appears to circulate
independently from the human population in swine in
several countries worldwide. Recently we and others found
evidence for the emergence of reassortants between
H1N1pdm and authentic porcine influenza virus line-
ages in Germany. In particular, a reassortant lineage of
subtype H1pdmN2 which carried seven segments of the
H1N1pdm virus and a neuraminidase of subtype 2 that
was derived from different porcine or human HxN2
lineages, circulated stably [9,13].
Measures aiming at control of swine influenza must be
based on subtype-specific virological and serological diag-
nosis. Real-time RT-PCR (RT-qPCR) has provided ample
applications for rapid and sensitive molecular virological
diagnosis [14]. Serology in swine influenza has been founduseful for retrospective epidemiological investigations
e.g., [15], estimation of disease incidence e.g., [16], and
control of vaccination success e.g., [17]. Several commer-
cial ELISAs for detection of generic IAV nucleocapsid
protein (NP)-specific antibodies in pigs are available and
recommended for use e.g., [18]. With regard to detection
of antibodies at the subtype-specific level the hemagglu-
tination inhibition assay (HI) is still held gold standard
despite several draw-backs of this method including time-
and labour-consuming performance and dependence on
labile and difficult-to-standardize components (viral anti-
gen, erythrocytes). Furthermore, due to interference of
antibodies against the viral neuraminidase component
interpretation of HI-results are particularly difficult [19,20].
Antibodies to the IAV hemagglutinin protein (HA) become
detectable by HI assay from the second week post infection
on and HI titers correlate with protection from clinically
overt disease [21,22].
Despite mentioned problems of HI assays very few
swine influenza ELISA applications aiming at subtype
differentiation at the antibody level have been reported
and the current commercially available assays for sub-
types H1 and H3 have not superseded HI assays, at least
in Europe [23]. The reported lack of sensitivity of these
assays may be related to the American origin of the IAV
isolates used which are antigenically distinct from those
circulating in Europe. Low specificity of these assays may
be caused by use of whole virion preparations which
contain group specific antigens such as the nucleocapsid
protein.
Here we show that recombinant HA1 antigen of European
swine influenza viruses which was bacterially expressed
and refolded in vitro can be used in indirect ELISAs for
detection and differentiation of subtype-specific antibodies
in porcine sera.
Results
Bacterial expression of antigenic influenza HA1 protein
The HA1 protein fragments of seven recent swine influenza
virus isolates (Table 1) were bacterially expressed (pET19b
expression vectors) and co-translationally monobiotinylated
by overexpressed bacterial BirA biotin ligase (pBIRAcm
vector). In addition, the full-length nucleocapsid protein
of one of the seven isolates was expressed similarly. The
recombinant proteins sequestered into bacterial inclu-
sion bodies. Purified bacterial inclusion body proteins
were subjected to SDS-PAGE under reducing conditions
for detection by Western blot analysis (Figure 1). Using
an anti-biotin monoclonal antibody, recombinant pro-
teins of expected molecular weights (HA-1 38 +/− 3 kD;
NP ca, 56 kD) are depicted in Figure 1A. No further
protein bands were identified and no biotinylated pro-
teins were detected in a control which consisted of a
clarified lysate of Rosettagami E. coli cells which had
Table 1 Origin and properties of porcine influenza viruses used in this study for generation of recombinant proteins
Identification Subtype HAa Lineage Sequence HA Sequence NPb
A/Germany/R26/2011 H1N1pdm Pandemic 2009 EPI356430c n.d.
A/swine/Germany/R1738/2010 H1N1 Eurasian avian-like EPI411955 EPI426141
A/swine/Germany/R1931/2011 H1N2 Eurasian avian-like reassortant EPI412039 n.d.
A/swine/Germany/R1207/2010 H1N2 Eurasian human-like reassortant EPI411941 n.d.
A/swine/Germany/R2035/2011 H1pdmN2 Pandemic 2009 reassortant EPI356453 n.d.
A/swine/Germany/R96/2011 H3N2 Eurasian human-like reassortant EPI411978 n.d.
A/swine/Germany/R76/2011 H3N2 Eurasian human-like reassortant EPI411965 n.d.
a HA - hemagglutinin.
b NP – nucleocapsid.
c Sequence accession number in EpiFlu database.
n.d. - not determined.
Figure 1 Detection of biotinylated recombinant HA1 hemagglutinin and nucleocapsid proteins of European porcine influenza viruses.
An amount of approximately 20 μg of recombinant protein was loaded onto each lane and subsequently probed by an anti-biotin monoclonal
antibody (A), H1N1pdm (Bavaria/74) specific porcine serum OM46 (B) H1N1av (R681/11) specific ferret serum EL1 (C), H1N2 (Bakum/1800)specific
porcine serum OM1 (D) or H3N2 (R655/12) specific ferret serum EL2 (E) as described in materials and methods. Recombinant antigens in lanes:
1 – R26/11 H1N1pdm, 2 – R2035/11 H1pdmN2, 3 – R1207/10 H1N2, 4 – R1738/11 H1N1av, 5 – R1931/11 H1N2, 6 – R76/11 H3N2, 7 – R96/11
H3N2, 8 - nucleocapsid protein of A/swine/Germany/R96/2011 (H3N2), N - Bacterial lysate of Rosettagami cells carrying the BirA plasmid and an
empty pET19b vector. The approximate molecular weight of recombinant HA1 (38 kD) and NP (56 kD) is indicated.
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vector and pBIRAcm. The NP protein showed liability
to proteolytical degradation as shown by a few and weak
bands of lower molecular weight (Figure 1A, lane 8).
Thus, the chosen bacterial co-expression system specif-
ically produced biotinylated recombinant HA1 and NP
proteins which could be successfully purified from in-
clusion bodies.
The antigens reacted also with sera from IAV infected
pigs and ferrets (Figure 1B-E; Table 2). The NP-antigen,
although derived from a porcine H3N2 virus, was recog-
nized by sera raised against four porcine IAV lineages
(H1N1pdm, H1N1av, H1N2, and the homologous H3N2)
as shown each in lanes 8 of Figure 1, panels B – D. A
porcine serum raised against H1N1pdm was specific for
the HA1 proteins of H1N1pdm and the reassortant
H1pdmN2 (Figure 1B, lane 1 and 2). Serum from a ferret
experimentally infected by an H1N1av isolate strongly
reacted with homologous H1av HA1 proteins (Figure 1C,
lane 4) but cross-reacted weakly also with other H1 HA1
recombinant proteins. An H1N2-specific porcine serum
(Figure 1D) similarly showed strong specific staining
with the homologous H1N2 HA1 (lane 3) and produced
weaker signals with other recombinant HA1 antigens
(e.g., lanes 2, 5). A ferret anti-H3 serum proved to be
subtype-specific (Figure 1E, lanes 6 and 7).
Determination of cut-off values for indirect ELISAs using
recombinant NP and HA1 proteins
Using the biotin residue of the recombinant NP and HA1
proteins, streptavidin ELISA plates were coated with
0,5 μg of recombinant protein per well and then blocked.
Sera to be tested were prediluted 1:200 and species-Table 2 HI titres of porcine and ferret post infection sera use
serum-antigen pairs depicted in bold)
Serum raised against Subtype Host
A/swine/Belzig/2/2001 H1N1av Swine (OM8)
A/swine/Germany/ R681/2011 H1N1av Ferret (EL1)
A/swine/Bakum/1832/ 2000 H1N2 Swine (OM1)
A/swine/Bayern/74/ 2009 H1N1pdm Swine (OM46)f
A/swine/Germany/ R2035/2011 H1pdmN2 Swine (OM15/4)
A/swine/Belzig/54/ 2001 H3N2 Swine (R4)
A/swine/Germany/ R655/2012 H3N2 Ferret (EL1)
Unknown, field serum Pan swine
Unknown, field serum None swine






* – Log2 titre (starting dilution 1:10).specific anti IgG antibodies conjugated with horseraddish
peroxidase were used to detect bound antibodies in this
indirect ELISA format. Seventy five sera from a total of 50
pigs were examined to determine cut-off values. These
pigs originated from the influenza-negative minipig breed-
ing cluster at FLI (n = 10) and from a swine farm which
tested continuously seronegative against IAV. None of
these sera tested positive in a commercial NP-specific
blocking ELISA (ID.Vet, France). Mean extinctions were
measured and standard deviations were calculated for the
indirect ELISAs using recombinant NP and HA1 (Table 3).
A porcine serum derived from a pig after multiple vaccin-
ation with four subtypes of European swine IAV possessed
high HI titres against H1av, H1N2, H1pdm and H3N2
(Table 2) and was chosen as standard positive control.
Likewise a negative porcine field serum with OD values
close to the upper cut-off value of the set of negative sera
was chosen as standard negative control. Based on these
control sera (Table 3) S/P ratios were calculated for the
set of 75 negative sera and the S/P mean plus 2 SD (re-
combinant HA1) or 3 SD (recombinant NP) were chosen
as cut-offs in the examination of porcine field sera by in-
direct ELISAs. The exact cut-off values for each assay are
presented in Table 3.
Specificity of HA1-specific indirect ELISAs
Subsequently recombinant HA1-antigens were used to
test sera obtained from experimentally infected pigs at
day 21 after inoculation (Figure 2). HI assays confirmed
a high specificity for these sera but also revealed minor
cross reactivities especially between sera raised against
subtype H1 viruses (Table 2). This was reflected in indir-
ect ELISA in which the highest S/P ratios (set to 1.0)d in Western blotting and indirect ELISA (homologous
Hemagglutination inhibiting titre
H1N1ava H1N2b H1N1pdmc H1pdmN2d H3N2e
4* 1 2 1 1
6 1 6 2 2
1 5 1 1 1
4 1 6 5 1
1 3 5 6 1
1 1 1 1 6
1 1 2 2 9
6 6 5 5 6
1 1 1 1 1
used in HI assays:
Table 3 Determination of cut-offs of indirect ELISAs based on recombinant NP and HA1 proteins
Serum samples Values Recombinant antigens
NP H1N1av H1N2 N1N1pdm H1pdmN2 H3N2
Negative sera Mean 0,11 0,03 0,06 0,03 0,04 0,14
N = 75 SD 0,08 0,03 0,10 0,08 0,07 0,14
X + 2SD 0,35* 0,08 0,25 0,19 0,18 0,41
Positive standard Mean 0,42 094 0,61 0,92 0,54 0,58
SD 0,02 0,01 0,01 0,01 0,02 0,02
Negative standard Mean 0,12 0,06 0,15 0,18 0,16 0,15
SD 0,02 0,01 0,00 0,01 0,03 0,01
Viruses used for production of recombinant proteins:





* - For NP a cut-off of 3 SD was used.
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recombinant HA1 protein pair. However, cross reactions
were also evident by indirect ELISA, particularly among
proteins of the H1 lineages. In general, cross reactions
resulted in S/P ratios well below 0.5 although a serum
raised against pandemic H1 could not distinguish pan-
demic H1 from reassorted H1pdmN2 and vice versa.Figure 2 Specificity of an indirect ELISA based on recombinant hema
obtained at day 21 of infection experiments in swine using the following v
Belzig/2/2001, H1N2 – Porcine serum OM1 against A/swine/Bakum/1832/20
H1pdmN2 – Porcine serum OM15/4 against A/swine/Germany/R2035/2011
recombinant HA1 antigens were produced from the following viruses: H1N
R1207/2010; H1N1pdm – A/Germany/R26/2011; H1pdmN2 – A/swine/GermIn order to test whether the observed serum cross re-
activities were due to low-affinity antibody species, avidity
assays were performed. Indirect ELISA assays were ex-
tended by an urea washing step for 10 minutes at room
temperature before second antibody conjugate was added.
As shown in Table 4, urea treatment diminished anti-
body reactivity against heterologous recombinant HA1gglutinin fragment HA1 of porcine influenza A viruses. Sera were
iruses for inoculation: H1N1av – Porcine serum OM8 against A/swine/
00, H1N1pdm – Porcine serum OM46 against A/Bayern/74/2009,
, H3N2 – Porcine serum R4 against A/swine/Belzig/54/2001. The
1av – A/swine/Germany/R1738/2010; H1N2 – A/swine/Germany/
any/R2035/2011; H3N2 – A/swine/Germany/96/2011.
Table 4 Serum avidity in indirect HA1 ELISA
Recombinant HA Serum specificity
H1N1pdm–A/Bayern/74/2009a H1N1av –A/swine/Belzig/2/2001 H3N2 – A/swine Belzig/54/2001
No urea Urea AVI (%) No urea Urea AVI (%) No urea Urea AVI (%)
A/Germany/R26/2011 (H1N1pdm) 2,332b 1,273 55 1,011 0,163 16 0,286 0,108 38
A/Swine/Germany/R2035/2011 (H1pdmN2) 1,359 0,266 20 0,292 0,109 37 0,306 0,099 32
A/Swine/Germany/R1738/2010 (H1N1av) 0,209 0,112 54 1,241 0,312 25 0,291 0,107 37
A/swine/Germany/R1207/2010 (H1N2) 0,176 0,16 91 0,078 0,061 78 0,087 0,06 69
A/swine/Germany/R76/2011 (H3N2) 0,182 0,111 61 0,159 0,121 76 0,768 0,147 19
a Subtype and designation of influenza A virus isolate used to raise the respective serum.
b Bold face indicates homologous rec HA1 – serum pair.
AVI (%) - percentage avidity index.
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HA1-serum reactions as well. Thus, urea treatment grossly
decreased sensitivity with no apparent benefit on speci-
ficity. In further assays therefore urea washing steps
were omitted.
Detection of influenza-specific antibodies in sera of
experimentally infected swine
In a next step the dynamics of antibody development after
experimental influenza virus infections of pigs was exam-
ined. Experimental infections had been carried out previ-
ously using a pandemic H1 virus (A/sw/Germany/R708/
2010), an H1pdmN2 reassortant (A/sw/Germany/R2035/
2011), and an H1N1av isolate (A/sw/Germany/R248/2010).
Sera obtained at different time points post infection were
available for testing by a commercial NP blocking ELISA
(ID.Vet, France), the indirect ELISAs specific for recom-
binant NP and for the homologous HA1 proteins, re-
spectively. In addition, HI titers measured against the
homologous virus were compared. Results are presented
in composite Figure 3. The data show that antibody dy-
namics in experimentally infected swine can be accurately
followed using the indirect ELISA formats. The results
compare favorably with the commercial NP blocking
ELISA and homologous HI.
Detection of influenza-specific antibodies in porcine
field sera
Finally, reactivity of a collection of 207 porcine field sera
was compared by testing sera in HI assays, commercial
NP blocking ELISA and indirect ELISAs with recombinant
NP and HA1- antigens. These sera represented daily rou-
tine diagnostic submissions. As regards the HI assay, a
serum was rated qualitatively positive for influenza A spe-
cific antibodies if it showed an HI titre of ≥ 40 (≥ 3 log2,
starting dilution 1:10) against at least one of the four anti-
gens (H1N1av, H1N2, H1N1pdm, H3N2) used for testing.
Depicting the results of the commercial NP blocking
ELISA, the indirect NP ELISA and the sum of the HI as-
says using a Venn diagram (Figure 4; [24]), an overall highdegree of agreement was visually evident. The majority
of results was backed by all three or at least two of the
assays. However, in the HI assays, a comparatively high
number of 26 sera revealed positive results just above
the threshold (3 or 4 log2) which were not supported by
other assays (Figure 4).
Inter-rater agreement [25] was used to evaluate results
of indirect ELISAs using recombinant HA1 compared to
HI titres. While excellent and good agreements were seen
for the H3 (κR96 = 0,8255 [95% CI 0,6997-0,9513]) and the
pandemic H1 antigens (κR26 = 0,7772 [0,6917-0,8627];
κR2035 = 0,661 [0,5643-0,7577]), respectively, only mod-
erate agreement was signaled for the H1av (κR1738 =
0,5722 [0,4401-0,7043]) and H1N2 (κR1207 = 0,5083 [0,3359-
0,6807]) antigens. A graphical analysis revealed that correl-
ation between HI titres and S/P ratios was stronger for
higher but less tight for sera with lower HI titres (Figure 5,
examplified for recombinant H1av HA1 antigen). A good
agreement (κHOLDING7 = 0,625 [0,374-0,876]) across all
indirect ELISAs was seen when results were compared
based on holding level instead of individual sera (Table 5).
Discussion
Serodiagnosis of porcine influenza virus infections in
Europe and elsewhere is significantly challenged by co-
circulation of several subtypes, and use of multivalent
vaccines further complicates this situation. While generic
antibodies directed against the well conserved influenza
virus NP protein can be detected by commercial blocking
ELISAs, the differentiation of subtype-specific antibodies
requires use of the fastidious HI assay. Subtype-specific
ELISA assays suitable for high throughput investigations
of porcine sera would aid in promoting more intense
studies on porcine influenza seroepidemiology.
Aiming to develop such assays we have successfully
expressed recombinant full-length NP and HA1 fragments
in bacteria and refolded proteins in vitro. Recombinant
proteins were co-translationally mono-bitoinylated which
facilitated purification and binding to solid, streptavidin-
coated supports. Previous work by [26] has shown that
Figure 3 Development of antibodies against viral nucleocapsid
and hemagglutinin fragment HA1 proteins in swine experimentally
infected with porcine influenza A viruses. Experimental infection
each of three pigs by A – A/sw/Germany/R708/2010 (H1pdmN1),
B – A/sw/Germany/R2035/2011 (H1pdmN2), and C – A/sw/Germany/
R248/2010 (H1N1av). Columns – HI titer against homologous virus
antigen; open triangle – indirect recombinant NP ELISA; black dot –
indirect recombinant HA1 ELISA (homologous antigen); open diamond –
commercial blocking NP ELISA (ID.Vet). Samples of days 7 and 14 were
unfortunately not available for experiment “C”.
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native conformation. Recombinant proteins representing
recent isolates of the major subtypes and lineages of por-
cine influenza virus currently circulating in Germany were
recognized by specific porcine or mustelid immune sera
in Western blotting and indirect ELISA. Dynamics of gen-
eric and subtype-specific antibody development in experi-
mentally infected swine as measured by recombinant
indirect ELISAs fully paralleled results obtained by a com-
mercial NP blocking ELISA and homologous HI assays.
However, despite use of the less conserved HA1 section
of the HA glycoprotein as diagnostic antigen residual
cross reactivity between the different subtypes was no-
ticed in both Western blot (Figure 1) and indirect ELISA
(Figure 2) even when using experimental post infection
sera which were reasonably discriminatory between sub-
types in HI assays (Table 2). Thus, a number of conserved
epitopes exists between the different subtypes in the HA1
which is not detected by the functional HI assay. Yet, a
considerable number of subtype-specific epitopes must
have been represented in the recombinant HA1 proteins
as well since, in indirect ELISA, the homologous HA1-
serum pairs always resulted by far in the highest signal
intensity (Figure 2). Human pandemic H1 HA1 repre-
sented by isolate R26/11 and that of the porcine-adapted
variant H1pdmN2 R2035/11 were indistinguishable by
Western blot and indirect ELISA although slight antigenic
differences have been reported when using an HI assay [9].
The comparative examination of porcine field sera
showed a variable agreement for the different recombinant
antigens when individual sera were compared. In particu-
lar, ELISAs based on recombinant H1av and H1N2 re-
vealed only moderate agreement when compared to HI.
Fewer sera scored positive in the indirect ELISAs com-
pared to HI assays. The majority of sera missed by the
indirect ELISA showed low HI titres (3 or 4 log2) while
reasonable correlation was seen between S/P ratios and
HI titres for higher-titred sera (Figure 5). The blurring
of results obtained with low-titred HI-positive sera may
be due to low sensitivity of the indirect ELISAs but
could as well have been caused by lack of specificity
of the HI assays; problems with reproducibility and
standardization of HI assays are notorious, especially
when testing low-titred sera [20]. In addition, the HI
assays here were carried out with antigens selected and
used in routine diagnosis while the recombinant antigens
were produced from more recent circulating viruses
and differed slightly in HA1 amino acid sequences (not
shown). This may have introduced further discrepancies
as observed for individual sera. However, when results
were compared on a herd basis a full match between HI
and indirect ELISA results was evident (Table 5). Herds
found to be seropositive by HI for a certain subtype were
similarly positive in the respective HA1 indirect ELISA.
Figure 4 Venn diagram of detection of NP-specific antibodies by commercial blocking ELISA (hatched ellipsis) and indirect ELISA
(recombinant NP; red ellipsis) in porcine field sera (n = 207) compared with hemagglutination inhibition assays (white ellipsis). Eleven sera
produced congruently negative results in all three tests.
Figure 5 Comparison of HI titres measured against porcine avian-derived H1N1 isolate A/swine/Germany/R248/2010 and S/P ratios
obtained by indirect ELISA using recombinant HA1 antigen of avian-derived H1N1 isolate A/swine/Germany/R1738/2011. Black dots –
congruent qualitative result; white dots – incongruent qualitative result; HI titre shown as log2 series (starting dilution 1 = 1:10); dotted lines
represent cut-off values.
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Table 5 Results of recombinant indirect ELISAs (iEIA) and HI or commercial NP-specific ELISA obtained with 207
porcine field sera compared on a holding base
Holding Sample NP H1av H1N2 H1pdm H1pdmN2 H3
cEIA IDVet iEIA HI iEIA HI iEIA HI iEIA HI iEIA HI iEIA
1 6a 5b 4 5 6 1 0 4 4 n.d. 2 0 0
2 16 15 12 14 16 3 0 13 16 n.d. 16 6 6
3 9 7 7 7 7 9 2 3 6 n.d. 4 5 3
4 7 7 7 7 7 7 7 7 7 n.d. 7 7 7
5 5 5 5 5 5 5 5 5 5 n.d. 5 5 5
6 30 30 28 30 29 1 0 28 26 n.d. 20 0 3
7 30 24 26 22 22 3 1 17 15 n.d. 14 0 0
8 30 13 18 8 14 0 0 1 3 n.d. 3 0 0
9 30 18 28 28 26 0 1 26 21 n.d. 15 0 0
10 23 3 12 9 7 3 0 0 0 n.d. 0 1 0
11 13 11 12 13 13 3 1 12 11 n.d. 6 0 0
12 10 10 10 10 6 1 1 5 3 n.d. 3 0 0
a Number of sample obtained in holding.
b Number of sample rated positive in the respective assay.
n.d. Not determined.
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tested negative by the corresponding indirect ELISA. This
indicates that on herd base the HI assay may be replaced,
without loss of diagnostic quality, by the indirect ELISAs.Conclusions
Due to the ongoing antigenic diversification of porcine
influenza viruses worldwide and new reassortant lineages
springing up here and there serological diagnosis of por-
cine influenza becomes ever more demanding. Subtype
and lineage-specific assays suitable for high throughput
analysis will be required to cope with such diagnostic
challenges. The recombinant mono-biotinylated HA1 pro-
teins presented here as diagnostic antigens in indirect
ELISAs provided an interesting alternative in this respect
to HI assays. Further refinements of this strategy, e.g., by
using lineage-specific monoclonal antibodies for competi-
tion or an immune-complex binding assay format, should
be further investigated to replace HI assays.Material and methods
Virus and cell culture
Influenza A viruses were propagated in serum-free MDCK
cell cultures in the presence of TPCK-trypsin as detailed
elsewhere [11]. Isolates were obtained from the virus re-
pository maintained at the Friedrich-Loeffler-Institut.
Molecular characteristics of recent porcine field isolates
have previously been reported [9]. A list of viruses usedin this study for production of recombinant proteins is
provided in Table 1.Bacterial expression, in vivo biotinylation and purification
of influenza virus HA1 and NP proteins
The HA1 fragments of the viral hemagglutinin open-
reading frames (ORF) were cloned into the pET19b vector
by a target-primed technique using Phusion polymerase
amplification and Dpn I digested amplificates [27]. Se-
quences of primers are available on request. Expressed
sequences stretched from the first amino acid of the
mature protein to the arginin residue immediately prox-
imal to the first glycin residue of the HA2 fusion peptide.
Downstream of this arginin residue an Avi-Tag consensus
sequence [28] was inserted. The central lysin residue of
the 15 amino acid Avi-Tag sequence provides an acceptor
site for covalent linkage of D-biotin which is specifically
catalyzed by the bacterial biotin transferase BirA [29].
HA1-pET19b expression constructs were co-transformed
into Rosettagami E. coli with plasmid pBIRAcm (Avidity,
Aurora, CO, U.S.A.) for overexpression of BirA. Dually
transformed cells were selected using ampicillin and chlor-
amphenicol (CM). Since CM is also required to maintain
the genotype of Rosettagami E. coli cells, presence of both
plasmids in selected colonies had to be confirmed by
plasmid/insert-specific PCRs (primer sequences avail-
able on request). TYH medium supplemented with D-biotin
at a concentration of 50 μg/ml was used for expres-
sion of co-translationally mono-biotinylatied Avi-tagged
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capsid gene of the porcine influenza virus isolate R1738/10
was cloned and expressed similarly. However, the Avi-Tag
was placed at the N-terminus of the protein. Lysates of
Rosettagami cells transformed with plasmid pBIRAcm and
an empty pET19b vector were used as a negative expres-
sion control.
Monobiotinylated bacterially expressed recombinant
proteins were purified from inclusion bodies (IBs) by
centrifugation and washing steps as previously described
[26]. Proteins sequestered in purified IBs were then
subjected to solubilization in 6 M guanidin-HCl and
refolding using a panel of up to 30 different primary and
up to nine secondary buffer conditions in a stepwise
solubilization strategy using the ProteoStat kit (Enzo,
Lörrach, Germany). Protein solubilization and reactivity
were screened with conformation-dependent monoclo-
nal antibodies and specific polyclonal sera in ELISA to
sort out optimal refolding conditions for each of the
recombinantly expressed proteins. Here, refolding condi-
tions were used which had been validated using avian
influenza virus H5 HA1 protein and two conformation-
dependent monoclonal antibodies, 3H12 and 5 F3 (see
[30], for properties of monoclonal antibodies). Final
concentrations of recombinant proteins in appropriate
refolding buffers were measured using a Coomassie pro-
tein assay kit (ThermoScientific, Rockford, IL, U.S.A.).
Production of subtype-specific antisera
Pigs or ferrets were experimentally infected by the oronasal
route with 106 TCID50 of MDCK cell culture-grown in-
fluenza viruses in 1 ml cell culture medium using a
nebulizer device (Wolfe Tory Medical, Salt Lake City,
Utah) as previously described [31]. All experiments had
received legal approval by an ethics commission (LALLF
M-V/TSD/7221.3-2.5-004/10). Prior to infection animals
were tested seronegative for influenza NP-specific anti-
bodies in a commercial blocking ELISA (ID.Vet). Virus
isolates used for infection are listed in Table 2. Blood
samples used in further serological studies were obtained
on day 21 post inoculation (p.i.). Reactivity of post infec-
tion sera in hemagglutination inhibition assays is detailed
in Table 2.
Origin of field sera
Porcine field sera from 12 swine holdings in Germany
were submitted for routine diagnostic procedures. The
history of these holdings for vaccination against influenza
and/or clinical episodes of influenza virus infection was
not documented.
Indirect ELISA
Bacterially expressed proteins in refolding buffer were
adjusted to a concentration of 5 μg/ml using TRIS-buffered saline (TBS). A total of 100 μl per well was used
for binding to streptavidin-coated plates for 2 hours at
room temperature or overnight at 4°C. Each plate in-
cluded different recombinant antigens for each row with
following strains: A:SIV/R1738/10 (H1N1),B: SIV/ R1207/
11 (H1N2),C: –SIV/ R26/11 (H1N1pdm)D: SIV R2035/11
H1pdmN2, E: SIV/– R1931 /11 (H1N2), F: R76/11 (H3N2),
G: R96/11 (H3N2), H: R1738/10 nucleocapsid protein.
After washing wells were blocked using 5% nonfat milk-
TBS containing 0.05% Tween 20 (TBST) (see Postel et al.,
2011) for 2 hours at room temperature and then washed
four times with TBST. Individual sera (100 μl per well, pre-
diluted 1:200 in sample dilution buffer [ID.Vet, Montpellier,
France]) were pipetted into columns (1A-1H) of the micro-
titre plate. This procedure assured that the reactivity of
each serum against all antigens was measured in the same
plate. Sera were incubated at room temperature for 1 hour.
Wells were washed again four times with TBST before
100 μl of appropriately diluted goat-anti-swine IgG peroxi-
dase conjugate (Dianova) was added for one hour at room
temperature. Antibody was removed and after a final wash-
ing cycle with TBST, 50 μl of chromogenic TMB substrate
was added. OD450 values were measured after 10 minutes
of incubation and addition of 50 μl of 1 N H2SO4 to each
well. Results were calculated and expressed in S/P units:
ODTest‐ODBackground
ODPositive control‐ODBackground
 100 ¼ S=P
Avidity measurement of sera by indirect ELISA
The indirect ELISA was performed as described above.
However, after incubation of sera in the wells a washing
step using urea in TBST was carried out. Different urea
concentrations (0.5 and 2 M) and incubation times were
evaluated, Final assays were carried out with 6 M urea
for ten minutes at room temperature. Consecutive wash-
ing steps and conjugate incubation were carried out with
TBST without urea. The sera were tested in parallel with
and without the urea-buffer washing step and an avidity
index (AVI) was calculated:
OD sample without urea
OD sample with urea
 100 ¼ AVI
Generic nucleocapsid protein blocking ELISA (NP-bEIA)
For detection of group specific antibodies a commercial
NP-bEIA was purchased (ID.Vet, Montpellier, France)
and used according to recommendations of the manu-
facturer. Accordingly, samples were considered positive
if the S/N (sample OD450/negative-control OD450 × 100)
ratio was less than 45%, negative if the S/N ratio was more
than 50%, and doubtful if the S/N ratio was between 45%
and 50%.
Zhao et al. Virology Journal 2013, 10:246 Page 11 of 12
http://www.virologyj.com/content/10/1/246Hemagglutination inhibition assay (HI)
HI assays were performed according to O.I.E. recom-
mendations essentially as described by [31]. Four hemag-
glutinating units of cell culture-grown influenza viruses
were used throughout. All porcine and ferret sera were
heat-inactivated for 30 minutes at 56°C and treated
with receptor-destroying enzyme (neuraminidase from
Bacillus subtilis).
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